Australasian Diabetes Congress 2025

The Program Organising Committee (POC) invites submissions of papers of original contributions on any topic related to the following categories.

GROUP 1: Genetics/Epigenetics/Epidemiology

01 Epidemiology

02 Genetics of type 1 diabetes

03 Genetics of type 2 diabetes

04 Monogenic forms of diabetes

05 Environmental factors (viruses, nutrients, toxins)

06 Diabetes epigenetics

07 Prediction and prevention of type 1 diabetes

08 Prediction of type 2 diabetes

09 Prevention of type 2 diabetes

10 Risk of diabetes in immigrant populations

GROUP 2: Islets/Transplantation/Immunology type 1 diabetes

11 Developmental biology, pancreas

12 Stem cells and beta cell generation

13 Transcriptional regulation and protein synthesis, pancreas

14 Insulin secretion in vitro and exocytosis

15 Beta cell signal transduction

16 Beta cell damage, degeneration and apoptosis

17 Experimental immunology and animal models of type 1 diabetes

18 Clinical immunology

19 Inflammatory mediators in the pathogenesis of type 1 diabetes

20 Pancreas and islet transplantation

GROUP 3: Pathophysiology/Metabolism I

21 Insulin action

22 Insulin sensitivity and resistance

23 Insulin secretion in vivo

24 Gastro-entero pancreatic factors

25 Other hormones

26 Glucose transport

27 Carbohydrate metabolism

28 Protein metabolism

29 Exercise physiology

GROUP 4: Pathophysiology/Metabolism II

30 Inflammation in type 2 diabetes

31 Animal models of type 2 diabetes

32 Lipid metabolism

33 Adipose tissue biology and adipocytokines

34 Inflammation in obesity

35 Animal models of obesity

36 Weight regulation and obesity

37 Brain metabolism

GROUP 5: Clinical Science and Care I

38 Nutrition and diet

39 Oral therapies: secretagogues

40 Oral therapies: metformin, sensitizers and other non-secretagogues

41 SGLT inhibitors

42 Incretin based therapies

43 Novel agents

GROUP 6: Clinical Science and Care II

44 Insulin therapy

45 Devices

46 Hypoglycaemia

47 Health care delivery

48 Education

49 Psychological aspects

50 Socio-economic aspects

GROUP 7: Complications I

51 Pregnancy

52 Neuropathy: somatic

53 Neuropathy: autonomic, incl. erectile dysfunction

54 Diabetic foot and skin disorders

55 Retinopathy

56 Nephropathy

57 Hypertension

GROUP 8: Complications II

58 Cardiac complications

59 Macrovascular disease

60 Pathogenic mechanisms / complications

61 Dyslipidaemia, lipoproteins

62 Endothelium

63 Animal models with complications

64 Other complications

65 Diabetes in childhood

66 Cancer

67 Cognitive dysfunction and Alzheimer Disease

68 Non-alcoholic fatty liver disease (NAFLD)